tiprankstipranks
N4 Pharma PLC (GB:N4P)
LSE:N4P
Holding GB:N4P?
Track your performance easily

N4 Pharma (N4P) Technical Analysis

2 Followers

Technical Sentiment

Overall Consensus
Buy
9Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
2Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
N4 Pharma PLC’s (N4P) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting N4 Pharma PLC is a Buy.
N4 Pharma PLC’s (N4P) 20-Day exponential moving average is 0.64, while N4 Pharma PLC’s (N4P) share price is 0.65p, making it a Buy.
N4 Pharma PLC’s (N4P) 50-Day exponential moving average is 0.61, while N4 Pharma PLC’s (N4P) share price is 0.65p, making it a Buy.

N4 Pharma (N4P) Pivot Points

Nov 22, 2024, 12:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.67
0.68
0.67
0.68
0.67
0.68
0.67
Fibonacci
0.68
0.68
0.68
0.68
0.68
0.68
0.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

N4 Pharma (N4P) Moving Averages

Nov 22, 2024, 12:55 PM
Period
Simple
Exponential
MA5
0.65Sell
0.65Sell
MA10
0.65Sell
0.65Sell
MA20
0.65Buy
0.64Buy
MA50
0.60Buy
0.61Buy
MA100
0.55Buy
0.60Buy
MA200
0.63Buy
0.66Sell
N4 Pharma PLC’s (N4P) 10-Day exponential moving average is 0.65, while N4 Pharma PLC’s (N4P) share price is 0.65p, making it a Sell.
N4 Pharma PLC’s (N4P) 100-Day exponential moving average is 0.60, while N4 Pharma PLC’s (N4P) share price is 0.65p, making it a Buy.
N4 Pharma PLC’s (N4P) stock price is 0.65p and N4 Pharma PLC’s (N4P) 50-day simple moving average is 0.60, creating a Buy signal.
N4 Pharma PLC’s (N4P) stock price is 0.65p and N4 Pharma PLC’s (N4P) 100-day simple moving average is 0.55, creating a Buy signal.
N4 Pharma PLC’s (N4P) stock price is 0.65p and N4 Pharma PLC’s (N4P) 200-day simple moving average is 0.63, creating a Buy signal.

N4 Pharma (N4P) Technical Indicators

Nov 22, 2024, 12:55 PM
Name
Value
Implied Action
RSI (14)
53.00
Neutral
STOCH (9,6)
30.56
Neutral
STOCHRSI (14)
26.19
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
21.33
Neutral
Williams %R
-75.00
Buy
CCI (14)
-7.50
Neutral
ATR (14)
0.09
-
Ultimate Oscillator
35.33
Neutral
ROC
0.00
-
N4 Pharma PLC’s (N4P) Relative Strength Index (RSI) is 53.00, creating a Neutral signal.
N4 Pharma PLC’s (N4P) Trend Strength Indicator (ADX) is 21.33, creating a Neutral signal.
N4 Pharma PLC’s (N4P) Commodity Channel Index (CCI) is -7.50, creating a Neutral signal.

FAQ

Is N4P a Buy, Hold, or Sell?
Based on N4P’s technical indicators, N4P is a Buy.
    What is N4P’s RSI (14)?
    N4P’s RSI (14) is 53.00, which suggests N4P is a Neutral.
      What is N4P’s MACD?
      N4P’s MACD is 0.02, which suggests N4P is a Buy.
        What is N4P’s 5-day moving average?
        N4P’s 5-day moving average is 0.65, which suggests N4P is a Sell.
          What is N4P’s 20-day moving average?
          N4P 20-day moving average is 0.65, which suggests N4P is a Buy.
            What is N4P’s 50-day moving average?
            N4P’s 50-day moving average is 0.60, which suggests N4P is a Buy.
              What is N4P’s 200-day moving average?
              N4P’s 200-day moving average is 0.63, which suggests N4P is a Buy.
                What is N4P’s Williams % R (14)?
                N4P’s Williams % R (14) is -75.00, which suggests N4P is a Buy.
                  What is N4P’s CCI (14)?
                  N4P’s CCI (14) is -7.50, which suggests N4P is a Neutral.
                    What is the share price of N4 Pharma PLC?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis